跳至主要内容
临床试验/CTRI/2024/05/068120
CTRI/2024/05/068120尚未招募2 期

An open-label randomized controlled clinical study to compare the efficacy and safety of Saboos Isapgol with Syrup Cremaffin in patients with uncomplicated Da’imi-Qabz(Chronic Constipation) - Nil

Government Tibbi College and Hospital0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Patients having the complaints of:
  • 1.Abdominal pain or discomfort
  • 2.Reduced bowel movements (less than 3/week) or infrequent stools
  • 3.Sense of incomplete evacuation
  • 4.Nausea or flatulence
  • 5.Pain at defecation
  • 6.Straining at defecation
  • 7.Patient willing to sign the written informed consent to participate in this trial.

排除标准

  • 1.Below 20 years and above 60 years of patient.
  • 2.Pregnant and lactating women.
  • 3.Patients taking other drugs such as atropine and opium group.
  • 4.Patients taking any antacid medicine which has aluminium and calcium.
  • 5.Associated Complications like Diabetes mellitus, Hypertension,
  • Hyperthyroidism, anal fistula, anal fissure, haemorrhoids, hernia, ano-rectal
  • abscess, etc.
  • 6.Mentally retarded person and prisoners.
  • 7.Patients with chronic debilitating diseases, or neurologic abnormalities.
  • 8.Non ambulatory / Bed ridden patients.
  • 9.One who had previous surgery of the colon.
  • 10.Patient having diagnosed intestinal structural abnormality.
  • 11.Patient with phlegmatic temperament.
  • 12.Patient who’s not agree to give consent

研究者

发起方
Government Tibbi College and Hospital

相似试验